<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="172799">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00846599</url>
  </required_header>
  <id_info>
    <org_study_id>SUB730</org_study_id>
    <nct_id>NCT00846599</nct_id>
  </id_info>
  <brief_title>Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men</brief_title>
  <acronym>PERTH</acronym>
  <official_title>Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the postprandial (anytime after a meal) effect of
      different dietary fats on endothelial function in HIV-infected and HIV-uninfected men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study requires two visits. Once determined eligible by the study criteria, during the
      first visit the participant will be randomly placed to receive one of two high-fat meals.
      The participant will receive the other study meal during the second visit. At each visit,
      brachial artery ultrasounds will be performed before and 3 hours after the meal is eaten.
      The sample size is 50 subjects. This study will be conducted at the Clinical Research Center
      at Tufts Medical Center.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To measure flow-mediated dilation before and after eating the two study meals.</measure>
    <time_frame>Study visit 1 and 2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the effect of different dietary fats on endothelial function.</measure>
    <time_frame>Study visit 1 and 2</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>HIV Infection</condition>
  <condition>Cardiovascular Risk</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>High omega-3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>High saturated fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Omega-3 study meal</intervention_name>
    <description>Participant will eat a study meal high in omega-3 fatty acids.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saturated fat study meal</intervention_name>
    <description>Participant will eat a study meal high in saturated fat.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-infected white males who have identified themselves with concerns about diet or
        cardiovascular disease.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-positive white male aged &gt;18 years

          -  Under one of the following treatment categories:

               -  Treatment naive or have never taken any HIV medications

               -  Taking Kaletra

               -  Taking Sustiva

               -  Taking Atripla

        Exclusion Criteria:

          -  Smoker

          -  Pre-existing diagnosis or treatment for the following:

               -  Lipid disorder

               -  Cardiovascular disease

               -  High blood pressure

               -  Diabetes

          -  Acute opportunistic infection or malignancy within last 3 months or current therapy
             for either

          -  Active IV drug use
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra Mangili, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mari Imai</last_name>
    <phone>617-636-3496</phone>
    <email>cindy.imai@tufts.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alexandra Mangili, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.tufts.edu/med/nutrition-infection/research/dom/study-perth.html</url>
    <description>PERTH Study</description>
  </link>
  <verification_date>December 2009</verification_date>
  <lastchanged_date>December 2, 2009</lastchanged_date>
  <firstreceived_date>February 17, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Alexandra Mangili, MD, MPH</name_title>
    <organization>Tufts University School of Medicine</organization>
  </responsible_party>
  <keyword>brachial artery ultrasound</keyword>
  <keyword>brachial artery reactivity</keyword>
  <keyword>HIV</keyword>
  <keyword>human immunodeficiency virus</keyword>
  <keyword>cardiovascular risk</keyword>
  <keyword>omega three</keyword>
  <keyword>saturated fat</keyword>
  <keyword>sustiva</keyword>
  <keyword>atripla</keyword>
  <keyword>kaletra</keyword>
  <keyword>treatment naive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
